Prediabetes Is Associated with an Increased Risk of Testosterone Deficiency, Independent of Obesity and Metabolic Syndrome
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The association between type 2 diabetes and low testosterone has been well recognized. However, testosterone levels in men with prediabetes have been rarely reported. We aimed to investigate whether prediabetes was associated with an increased risk of testosterone deficiency. METHODS: This study included 1,306 men whose sex hormones was measured during a medical examination. Serum total testosterone and sex hormone-binding globulin were measured; free and bioavailable testosterone concentrations were calculated by Vermeulen's formula. Prediabetes was defined by impaired fasting glucose (IFG), impaired postprandial glucose (IPG), or glycated hemoglobin (HbA1c) 5.7%-6.4%. Logistic regression was performed to obtain the odds ratios (OR) for subnormal total testosterone (<300 ng/dL) or free testosterone (<6 ng/dL) in prediabetic and diabetic men compared with normoglycemic individuals, while adjusting for age, BMI, waist circumference, and metabolic syndrome (MetS). RESULTS: Normoglycemia, prediabetes, and diabetes were diagnosed in 577 (44.2%), 543 (41.6%), and 186 (14.2%) men, respectively. Prediabetes was associated with an increased risk of subnormal total testosterone compared to normoglycemic individuals (age-adjusted OR=1.87; 95%CI=1.38-2.54). The risk remained significant in all multivariate analyses. After adjusting for MetS, the OR in prediabetic men equals that of diabetic patients (1.49 versus 1.50). IFG, IPG, and HbA1c 5.7%-6.4% were all associated with an increased risk of testosterone deficiency, with different levels of significance in multivariate analyses. However, neither prediabetes nor diabetes was associated with subnormal free testosterone in multivariate analyses. CONCLUSIONS: Prediabetes is associated with an increased risk of testosterone deficiency, independent of obesity and MetS. After adjusting for MetS, the risk equals that of diabetes. Our data suggest that testosterone should be measured routinely in men with prediabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Men with DM also may have lower testosterone levels due to decreased hypothalamic gonadotropin-releasing hormone drive and/or damage to the testes.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1554]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
(1996) · Institutional Research Information System University of Turin (University of Turin) · doi:10.1111/j · Cited by 5,486
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 3×
“The free testosterone concentration calculated by this formula correlate well with the concentrations measured by equilibrium dialysis and ammonium sulfate precipitation, respectively [15], and the formula has been widely adopted by other investigators [1,2,13].”
MethodPrediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958 · cited 2×
“However, elevations in fasting and postprandial glucose levels may be caused by different mechanisms and may represent distinct stages of diabetes development [11,24-27].”
BackgroundBhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954 · cited 1×
“consensus on the guideline is that TRT be considered only in men with both TD and clinical symptoms [43].”
BackgroundLaaksonen, D. E., Niskanen, L., Punnonen, K., Nyyssönen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1036 · Cited by 920 · cited 2×
“However, recent studies showed that low SHBG can predict the future development of type 2 diabetes, independent of the testosterone concentration [7,35].”
BackgroundResultTabák, A. G., Jokela, M., Akbaraly, T. N., Brunner, E. J., Kivimäki, M., & Witte, D. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60619-x · Cited by 898 · cited 1×
“However, elevations in fasting and postprandial glucose levels may be caused by different mechanisms and may represent distinct stages of diabetes development [11,24-27].”
BackgroundHanefeld, M., Fischer, S., Julius, U., Schulze, J., Schwanebeck, U., Schmechel, H., Ziegelasch, H. J., & Lindner, J. (1996) · Diabetologia · doi:10.1007/s001250050617 · Cited by 873 · cited 1×
“Moreover, fasting and postprandial hyperglycemia have been shown to be associated with different levels of risk of disease, such as cardiovascular events and mortality [30,31].”
BackgroundLow Serum Testosterone and Mortality in Older Men
Laughlin, G. A., Barrett-Connor, E., & Bergstrom, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1792 · Cited by 798 · cited 1×
“Furthermore, as it has been shown that both prediabetes and low testosterone are independent risk factors for cardiovascular disease and event, and all-cause mortality [41,42], it would be interesting to evaluate whether TRT could decrease the risk of cardiovascular events and mortality in men with both TD and prediab…”
BackgroundKapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791 · cited 1×
“Testosterone replacement therapy (TRT) in hypogonadal men with type 2 diabetes and/or metabolic syndrome improves insulin sensitivity in the short-term [37-40].”
BackgroundPrevalence of hypogonadism in males aged at least 45 years: the HIM study
MULLIGAN, T., FRICK, M. F., ZURAW, Q. C., STEMHAGEN, A., & MCWHIRTER, C. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.00992.x · Cited by 767 · cited 1×
“Low total testosterone was defined by total testosterone <300 ng/dL [16-18], and low free testosterone was defined by free testosterone <6 ng/dL.”
BackgroundAbdul-Ghani, M. A., Tripathy, D., & DeFronzo, R. A. (2006) · Diabetes Care · doi:10.2337/dc05-2179 · Cited by 744 · cited 1×
“The diagnosis of MetS was based on the modified ATP III criteria for Asians [21], and one was considered to have MetS if any three of the following were met: 1) waist circumference >90 cm, 2) triglycerides >150 mg/dL, 3) high-density lipoprotein cholesterol <40 mg/dL, 4) blood pressure >130/85 mmHg, and 5) fasting glu…”
MethodSex hormone-binding globulin and risk of type 2 diabetes in women and men
Ding, E. L., Song, Y., Manson, J. E., Hunter, D. J., Lee, C. C., Rifai, N., Buring, J. E., Gaziano, J. M., & Liu, S. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0804381 · Cited by 726 · cited 1×
“And there is also evidence that mechanisms associated with the SHBG gene is involved in the pathogenesis of type 2 diabetes [36].”
BackgroundSelf-citationPrevalence of Symptomatic Androgen Deficiency in Men
Araujo, A. B., Esche, G. R., Kupelian, V., O’Donnell, A. B., Travison, T. G., Williams, R. E., Clark, R. V., & McKinlay, J. B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1245 · Cited by 720 · cited 1×
“Low total testosterone was defined by total testosterone <300 ng/dL [16-18], and low free testosterone was defined by free testosterone <6 ng/dL.”
BackgroundBarr, E. L. M., Zimmet, P. Z., Welborn, T. A., Jolley, D., Magliano, D. J., Dunstan, D. W., Cameron, A. J., Dwyer, T., Taylor, H. R., Tonkin, A. M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.685628 · Cited by 719
Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0804 · Cited by 631 · cited 3×
“The free testosterone concentration calculated by this formula correlate well with the concentrations measured by equilibrium dialysis and ammonium sulfate precipitation, respectively [15], and the formula has been widely adopted by other investigators [1,2,13].”
BackgroundMethodStellato, R. K., Feldman, H. A., Hamdy, O., Horton, E. S., & McKinlay, J. B. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.490 · Cited by 618
Oh, J.-Y., Barrett-Connor, E., Wedick, N. M., & Wingard, D. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.55 · Cited by 594 · cited 3×
“While there is a substantial body of evidence demonstrating the association between low testosterone and diabetes [1-7], few studies have reported the androgen status of men with prediabetes, which is considered the preceding stage of overt diabetes.”
BackgroundAraujo, A. B., O’Donnell, A. B., Brambilla, D. J., Simpson, W. B., Longcope, C., Matsumoto, A. M., & McKinlay, J. B. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031719 · Cited by 591
European Journal of Endocrinology
(2022) · European Journal of Endocrinology · doi:10.1530/eje · Cited by 587
Cavalot, F., Petrelli, A., Traversa, M., Bonomo, K., Fiora, E., Conti, M., Anfossi, G., Costa, G., & Trovati, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1005 · Cited by 569
Jones, T. H., Arver, S., Behre, H. M., Buvat, J., Meuleman, E., Moncada, I., Morales, A. M., Volterrani, M., Yellowlees, A., Howell, J. D., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1233 · Cited by 548 · cited 1×
“Testosterone replacement therapy (TRT) in hypogonadal men with type 2 diabetes and/or metabolic syndrome improves insulin sensitivity in the short-term [37-40].”
BackgroundClinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes
Kapoor, D., Aldred, H., Clark, S., Channer, K. S., & Jones, T. H. (2007) · Diabetes Care · doi:10.2337/dc06-1426 · Cited by 493 · cited 3×
“The free testosterone concentration calculated by this formula correlate well with the concentrations measured by equilibrium dialysis and ammonium sulfate precipitation, respectively [15], and the formula has been widely adopted by other investigators [1,2,13].”
BackgroundMethodLow testosterone levels are common and associated with insulin resistance in men with diabetes
Grossmann, M., Thomas, M. C., Panagiotopoulos, S., Sharpe, K., MacIsaac, R. J., Clarke, S., Zajac, J. D., & Jerums, G. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2177 · Cited by 468 · cited 2×
“While there is a substantial body of evidence demonstrating the association between low testosterone and diabetes [1-7], few studies have reported the androgen status of men with prediabetes, which is considered the preceding stage of overt diabetes.”
BackgroundWang, C., Jackson, G., Jones, T. H., Matsumoto, A. M., Nehra, A., Perelman, M. A., Swerdloff, R. S., Traish, A., Zitzmann, M., & Cunningham, G. (2011) · Diabetes Care · doi:10.2337/dc10-2339 · Cited by 366 · cited 2×
“While the mechanisms are not fully understood, current evidence suggests that the causative relationship between TD and diabetes might be bidirectional, or even multidirectional and interrelated with obesity, metabolic syndrome (MetS), sex hormone-binding globulins (SHBG), and other factors [8,9].”
BackgroundSelf-citationLow Testosterone in Men with Type 2 Diabetes: Significance and Treatment
Grossmann, M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0118 · Cited by 350 · cited 2×
“There is also evidence that the relationship between free testosterone and diabetes is confounded by total body fat or abdominal fat [9,13].”
BackgroundHeufelder, A. E., Saad, F., Bunck, M. C., & Gooren, L. (2009) · Journal of Andrology · doi:10.2164/jandrol.108.007005 · Cited by 349 · cited 1×
“Testosterone replacement therapy (TRT) in hypogonadal men with type 2 diabetes and/or metabolic syndrome improves insulin sensitivity in the short-term [37-40].”
BackgroundKalinchenko, S. Y., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J. G., Giltay, E. J., & Saad, F. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03845.x · Cited by 341 · cited 1×
“Testosterone replacement therapy (TRT) in hypogonadal men with type 2 diabetes and/or metabolic syndrome improves insulin sensitivity in the short-term [37-40].”
BackgroundCavalot, F., Pagliarino, A., Valle, M., Di Martino, L., Bonomo, K., Massucco, P., Anfossi, G., & Trovati, M. (2011) · Diabetes Care · doi:10.2337/dc10-2414 · Cited by 322
Haffner, S. M., Shaten, J., Stem, M. P., Smith, G. D., Kuller, L., & MRFIT Research Group (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008832 · Cited by 320
Meyer, C., Pimenta, W., Woerle, H. J., Van Haeften, T., Szoke, E., Mitrakou, A., & Gerich, J. (2006) · Diabetes Care · doi:10.2337/dc06-0438 · Cited by 308 · cited 1×
“However, elevations in fasting and postprandial glucose levels may be caused by different mechanisms and may represent distinct stages of diabetes development [11,24-27].”
BackgroundAssociation of Bioavailable, Free, and Total Testosterone With Insulin Resistance
Tsai, E. C., Matsumoto, A. M., Fujimoto, W. Y., & Boyko, E. J. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.861 · Cited by 307 · cited 4×
“There is also evidence that the relationship between free testosterone and diabetes is confounded by total body fat or abdominal fat [9,13].”
BackgroundMethodInfluential(2022) · Cineca Institutional Research Information System (Tor Vergata University) · doi:10.1161/circulationaha · Cited by 291
Kalinchenko, S. Y., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J. G., Giltay, E. J., & Saad, F. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04105.x · Cited by 267
Rosenstock, J., Klaff, L. J., Schwartz, S., Northrup, J., Holcombe, J. H., Wilhelm, K., & Trautmann, M. (2010) · Diabetes Care · doi:10.2337/dc09-1203 · Cited by 229 · cited 2×
“Although postprandial glucose has been used in lieu of a standard OGTT to define prediabetes in the literature [19], the clinical application of postprandial glucose has been controversial due to low reproducibility and a lack of a standardized method of measurement [32-34].”
MethodTests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus
Barr, R. G., Nathan, D. M., Meigs, J. B., & Singer, D. E. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-4-200208200-00011 · Cited by 215 · cited 1×
“Although postprandial glucose has been used in lieu of a standard OGTT to define prediabetes in the literature [19], the clinical application of postprandial glucose has been controversial due to low reproducibility and a lack of a standardized method of measurement [32-34].”
MethodMultiple Risk Factor Intervention Trial
Eberly, L. E., Stamler, J., Kuller, L. H., & Neaton, J. D. (2014) · Methods and Applications of Statistics in Clinical Trials · doi:10.1002/9781118596005.ch47 · Cited by 206
Goodman-Gruen, D., & Barrett-Connor, E. (2000) · Diabetes Care · doi:10.2337/diacare.23.7.912 · Cited by 203 · cited 1×
“Moreover, the Rancho Bernardo Study evaluated the sex hormone levels in 775 men and showed that men with IFG or IGT had lower total testosterone than those with normal glucose tolerance, after adjustment for age and BMI [22].”
MethodBergman, M. (2012) · Endocrine · doi:10.1007/s12020-012-9830-9 · Cited by 165
Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study
Simon, D., Preziosi, P., Barrett-Connor, E., Roger, M., Saint-Paul, M., Nahoul, K., & Papoz, L. (1992) · Diabetologia · doi:10.1007/bf00402551 · Cited by 157 · cited 1×
“Data from non-diabetic men have revealed an inverse association between insulin resistance and testosterone concentrations [12-14].”
BackgroundYeap, B. B., Chubb, S. A. P., Hyde, Z., Jamrozik, K., Hankey, G. J., Flicker, L., & Norman, P. E. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0348 · Cited by 128 · cited 1×
“Data from non-diabetic men have revealed an inverse association between insulin resistance and testosterone concentrations [12-14].”
BackgroundBasu, R., Barosa, C., Jones, J., Dube, S., Carter, R., Basu, A., & Rizza, R. A. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3056 · Cited by 121 · cited 1×
“However, elevations in fasting and postprandial glucose levels may be caused by different mechanisms and may represent distinct stages of diabetes development [11,24-27].”
BackgroundSex Hormone-Binding Globulin as an Independent Predictor of Incident Type 2 Diabetes Mellitus in Men
Lakshman, K. M., Bhasin, S., & Araujo, A. B. (2010) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq002 · Cited by 100 · cited 4×
“However, recent studies showed that low SHBG can predict the future development of type 2 diabetes, independent of the testosterone concentration [7,35].”
BackgroundResultInfluentialCorona, G., Rastrelli, G., Balercia, G., Lotti, F., Sforza, A., Monami, M., Forti, G., Mannucci, E., & Maggi, M. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02717.x · Cited by 69 · cited 1×
“[23]evaluated the impact of IFG on sexual health in a consecutive 3,451 men attending the clinic for sexual dysfunction, and found that IFG increases the risk of severe erectile dysfunction, reduced penile flow, and overt hypogonadism [23].”
BackgroundSaukkonen, T., Cederberg, H., Jokelainen, J., Laakso, M., Härkönen, P., Keinänen-Kiukaanniemi, S., & Rajala, U. (2011) · Diabetes Care · doi:10.2337/dc11-0183 · Cited by 46
Onat, A., Can, G., Çiçek, G., Ayhan, E., Doğan, Y., & Kaya, H. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0313-x · Cited by 39 · cited 2×
“Although postprandial glucose has been used in lieu of a standard OGTT to define prediabetes in the literature [19], the clinical application of postprandial glucose has been controversial due to low reproducibility and a lack of a standardized method of measurement [32-34].”
MethodPostprandial Glucose: Marker or Risk Factor?
Avogaro, A. (2011) · Diabetes Care · doi:10.2337/dc11-1442 · Cited by 29
Assessment of Postprandial Glucose Excursions Throughout the Day in Newly Diagnosed Type 2 Diabetes
Cichosz, S. L., Fleischer, J., Høyem, P., Laugesen, E., Poulsen, P. L., Christiansen, J. S., Ejskjær, N., & Hansen, T. K. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0199 · Cited by 24 · cited 1×
“Although postprandial glucose has been used in lieu of a standard OGTT to define prediabetes in the literature [19], the clinical application of postprandial glucose has been controversial due to low reproducibility and a lack of a standardized method of measurement [32-34].”
Method
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
The role of androgens in metabolism, obesity, and diabetes in males and females
Navarro, G., Allard, C., Xu, W., & Mauvais‐Jarvis, F. (2015) · Obesity · doi:10.1002/oby.21033 · Cited by 289
“Notably, testosterone deficiency has also been associated with impaired fasting glucose and glucose intolerance independently of obesity and metabolic syndrome in men (14).”
BackgroundPeriodontitis and implant complications in diabetes
Nibali, L., Gkranias, N., Mainas, G., & Di Pino, A. (2022) · Periodontology 2000 · doi:10.1111/prd.12451 · Cited by 164
Navarro, G., Xu, W., Jacobson, D. A., Wicksteed, B., Allard, C., Zhang, G., De Gendt, K., Kim, S. H., Wu, H., Zhang, H., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.03.015 · Cited by 171
“Notably, testosterone deficiency has also been associated with impaired fasting glucose and glucose intolerance independently of obesity and the metabolic syndrome in men (Ho et al., 2013).”
Prediabetes and associated disorders
Buysschaert, M., Medina, J. L., Bergman, M., Shah, A., & Lonier, J. (2014) · Endocrine · doi:10.1007/s12020-014-0436-2 · Cited by 183
Metadata
- Authors
- Ho, C.-H., Yu, H.-J., Wang, C.-Y., Jaw, F.-S., Hsieh, J.-T., Liao, W.-C., Pu, Y.-S., & Liu, S.-P.
- Affiliations
- National Taiwan University (TW)
- National Taiwan University Hospital (TW)
- Corresponding author
- Liu, Shih-Ping
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-09-12
- Volume
- 8
- Issue
- 9
- Pages
- e74173
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3772062
- OpenAlex
- W2143703466
- Cited by
- 40
- References
- 46
- Citations by year
- 2026: 4 · 2025: 2 · 2022: 7 · 2021: 2 · 2019: 6 · 2018: 4 · 2017: 2 · 2016: 4 · 2015: 5 · 2014: 4
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Update notices
- correction (2013-12-13)
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- prediabetes, androgen deficiency, type 2 diabetes, impaired fasting glucose, HbA1c, free testosterone, sex hormone-binding globulin, metabolic syndrome, obesity, men
- MeSH terms
- Blood Glucose, Cross-Sectional Studies, Disease Susceptibility, Humans, Male, Middle Aged, Obesity, Prediabetic State, Risk Factors, Gonadal Steroid Hormones, Testosterone, Odds Ratio, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
